WALTHAM, Mass. (AP) _ Kala Pharmaceuticals Inc. (KALA) on Monday reported a loss of $25.2 million in its fourth quarter.
On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 76 cents. Losses, adjusted to extinguish debt, were 75 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.
Kala Pharma shares have climbed 77 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $8.67, a drop of 51 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KALA at https://www.zacks.com/ap/KALA